Earlier research has consistently demonstrated that upregulation of BRCA1, CDC20, RBM8A and CAD promotes progression, invasion, metastasis and chemoresistance in HCC [24–27]. The gene discussed is RBM8A; the disease is hepatocellular carcinoma.